This Telehealth System Could Be Scaled Up Statewide To Treat Opioid Use Disorder
This Model Is Cheaper And Easier To Use Than The ER, LDI Fellow Argues In New Op-Ed
Opioid Epidemic
In Their Own Words
Federal officials and caregivers have been in a race to combat a surge in overdoses from the combination of the opioid fentanyl and the animal sedative xylazine. The Biden Administration declared the combination an “emerging threat” in April 2023, marking the first time that designation has ever been used. It was given for the sharp rise in overdoses and skin wounds that the combination was causing across the nation.
In June a large group of experts met under the auspices of the National Institute on Drug Abuse to review testing, treatment and wound care for this combination, also called Tranq Dope. Then in July came the release of a National Response Plan.
LDI Senior Fellow Jeanmarie Perrone, a leading addiction expert at the University of Pennsylvania, was co-chair of the NIDA meeting. Here are some highlights she culled from the event.
This Model Is Cheaper And Easier To Use Than The ER, LDI Fellow Argues In New Op-Ed
Policymakers Should Consider Reporting and Planning Procedures That Do Not Involve Child Protective Services
New Maps From LDI Researchers Show Progress in Locating Programs Where the Need Is Greatest
Xylazine and Telehealth Rule Exemptions Dominate Hearing
Delivered to the United States Senate Committee on Finance
Submitted to U.S. Senate Committee on Finance